Hjem › Amyloidose › North Carolina
Kliniske studier for Amyloidose i North Carolina
10 studier for Amyloidose søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Levine Cancer Institute, Charlotte
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Durham
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Charlotte
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Chapel Hill
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Charlotte
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Durham
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT04561518Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Atrium Health Levine Cancer Institute /ID# 255074, Charlotte
- Atrium Health Wake Forest Baptist Medical Center /ID# 255851, Winston-Salem
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Duke University Medical Center, Durham
RekruttererFase 3
Alder 18 til 90 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06128629Registry for Adults With Plasma Cell Disorders (PCD's)
- North Carolina Cancer Hospital, Chapel Hill
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 20. nov. 2025 · NCT03717844Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.